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A 52-year-old Japanese man presented for evaluation and treatment of rectal cancer. Screening computed tomography
revealed pancreatic arteriovenous malformations (P-AVMs) and abnormally expanded inferior mesenteric vein (IMV) that
resulted from P-AVMs. One-stage surgery for rectal cancer was dangerous so we first performed distal pancreatectomy
to cure P-AVM and thus normalize the abnormally expanded IMV. After the operation, the IMV was occluded by the
thrombi, and then the IMV became normal. We could perform safely radical laparoscopic surgery for rectal cancer. This
is the first case report of P-AVMs combined with rectal cancer.
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Pancreatic arteriovenous malformation (P-AVM) is a
vascular anomaly in which blood flows from the arterial
system directly into the portal venous system without
passing through the capillaries in the pancreas [1]. It is a
rare disease and less than 100 cases have been reported
in the English language literature.
The current report describes a patient with abnormally
expanded inferior mesenteric vein (IMV) resulting from
P-AVMs, which was revealed during preoperative screen-
ing computed tomography (CT) for rectal cancer. We first
performed distal pancreatectomy to cure P-AVMs, and
then the abnormally expanded IMV became normal. Sub-
sequently, we could perform laparoscopic abdominoperi-
neal resection safely.
Case presentation
A 52-year-old Japanese man presented at our hospital
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in any medium, provided the original work is pbeen diagnosed with rectal cancer by colonoscopy for
screening of rectal bleeding. He had a history of
chronic hepatitis C. He had no family history. He had
no tenderness of the abdomen, and no mass was palp-
able. Laboratory results were unremarkable. Barium
enema showed a filling defect at the rectal ampulla
(Figure 1). Colonoscopy revealed a type 2 tumor local-
ized in the lower rectum (Figure 2). Following biopsy,
the lesion was confirmed to be papillary adenocarcin-
oma. Contrast-enhanced CT (CECT) did not reveal
swollen lymph nodes or distant metastases but did
reveal multiple hypervascular spots in the pancreatic
body and tail and abnormally expanded IMV at an
arterial phase. During the arterial phase, there was early
filling of the portal vein, splenic vein, proximal portion
of the superior mesenteric vein, and the abnormally ex-
panded IMV. The IMV, which was approximately 10
mm in diameter, lead tortuously down to the pelvic
space and connected to the right internal iliac vein
(Figure 3). Angiography of the splenic artery confirmed
racemose vascular networks in the body and tail of the
pancreas and early venous return to the portal venous
system and the abnormally expanded IMV (Figure 4).an open access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Figure 1 Barium enema showed a filling defect at the rectal
ampulla (arrow).
Figure 2 Colonoscopy revealed a type 2 tumor localized in the lower
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abnormally expanded IMV resulting from P-AVMs was
diagnosed. Open distal pancreatectomy was first per-
formed to cure the P-AVMs and thus normalize the
abnormally expanded IMV. Surgery revealed a web-like
vascular network in the pancreatic body and tail. The
IMV was expanded approximately 10 mm in diameter.
The IMV poured into the superior mesenteric vein. We
performed distal pancreatectomy, preserving the IMV.
The splenic artery was cut at the root, and splenectomy
was performed immediately. The amount of blood loss
was 1,862 ml, and the operation time was 315 min.
After the first operation, the patient developed pancre-
atic fistula (International Study Group of Pancreatic
Fistula Grade A), which improved after conservative
treatment. CECT showed occlusion of the abnormally
expanded IMV by thrombi on postoperative day (POD)
17 (Figure 5). He underwent two courses of preoperative
chemotherapy with the CapeOX regimen for 21 days
(oxaliplatin: 130 mg/m2 drip infusion day 1, capecita-
bine: 2,000 mg/m2 oral administration days 1 to 15)
from POD 43. CECT showed no abnormal vessels in his
abdomen on POD 89 (Figure 6). We performed radical
surgery for rectal cancer on POD 105.
We did not find any abnormal vessels during the second
operation. We performed laparoscopic abdominoperinealrectum.
ac d
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Figure 3 Hypervascular spots and abnormally expanded IMV. (a) Preoperative CECT revealed hypervascular spots in the pancreatic body and
tail (arrowhead). (b) Abnormally expanded IMV (arrow). (c) Abnormally expanded IMV (arrow) in the pelvic space. (d) 3D reconstruction.
Figure 4 Racemose vascular networks in the pancreas, early
venous return, and abnormally expanded IMV. Preoperative
angiography confirmed racemose vascular networks in the body
and tail of the pancreas (arrowhead), and early venous return to the
portal venous system and the abnormally expanded IMV (arrow).
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rectal cancer. The few adhesions in his abdomen were
easily dissected. The amount of blood loss was 75 ml,
and the operation time was 353 min. Histological
examination showed papillary adenocarcinoma with a
villotubular adenoma component and rectal ulcer
scarring. Histological assessment revealed a grade 2
therapeutic effect for nonsurgical cancer therapy. His
postoperative course was good except for surgical site
infection of the perineal lesion, and he was discharged
on POD 42 after the second operation.
Discussion
P-AVM is a rare disease that was first reported in 1968
by Halpern et al. [2]. The vascular anomaly is present in
the pancreas, in which blood flows from the arterial
system directly into the portal venous system, without
passing through the capillaries in the pancreas. Some pa-
tients have a clinical presentation such as epigastralgia
and gastrointestinal bleeding; others are asymptomatic
[1]. The diagnosis is usually confirmed by angiography
and CECT. The angiographic characteristics of P-AVM
may include the following: (1) dilated and tortuous feed-
ing arteries from the splenic artery, gastroduodenal
artery, or small pancreatic arteries; (2) an intratumoral
vascular network followed by a transient dense pancreatic
a b
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Figure 5 CECT on POD17 showed occlusion of the abnormally expanded IMV by the thrombi (arrow). (a, b) The level in which IMV poring
into superior mesenteric vein. (c, d) Occluded IMV in lower level.
a b
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Figure 6 CECT on POD89 showed no abnormal vessels. (a, b) The level in which IMV poring into superior mesenteric vein. (c, d) Pelvic space.
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in imaging studies; (3) early filling of draining veins such
as the portal vein at the arterial phase; and (4) early dis-
appearance of the pancreatic stain [1]. The typical CT
features are the presence of a conglomeration of strong
nodular staining and early enhancement of the efferent
drainage veins during the arterial phase [3].
Surgical resection, transarterial embolization (TAE),
and irradiation are reported to treat P-AVMs [4-8]. In
2013, Chou et al. reviewed the literature and stated that
the most common treatment for P-AVM was surgery
(43.8%), followed by TAE (11.2%), combination of sur-
gery and TAE (10.1%), and radiotherapy (2.2%) [1]. In
our case, abnormally expanded IMV resulting from P-
AVMs was revealed by staging CECT for rectal cancer.
To the best of our knowledge, this is the first report of
P-AVMs combined with rectal cancer. We could not
find any case report published in English in PubMed
using the following keywords, pancreatic arteriovenous
malformation and rectal cancer, pancreatic AVM, and
rectal cancer.
The IMV was abnormally expanded throughout its
length. It led into the pelvic space tortuously and was
connected to the right internal iliac vein. One-stage sur-
gery for rectal cancer was considered to be dangerous
because of the high risk of massive intraoperative bleed-
ing. Furthermore, the contracted pelvis makes it diffi-
cult to stop the bleeding. Therefore, we decided to cure
P-AVMs first and thus normalize the abnormally
expanded IMV. Distal pancreatectomy was considered
to be most feasible in our case because, although there
were multiple AVMs, they were located in the pancre-
atic body and tail. It was clear from CECT and angiog-
raphy that the feeding arteries of the P-AVMs were
branches from the splenic artery. Although TAE was
considered for treatment of the P-AVMs in our case,
distal pancreatectomy is a better treatment to reduce
the blood flow to the abnormally expanded IMV. The
failure rate of TAE is reported to be 37% and additional
treatment is needed, including surgery [2,9-11]. Song
et al. state in their review that TAE is effective if there
is a single apparent feeding artery [6]. If the P-AVMs
are multiple, TAE is thought to be difficult [12].
In the initial operation, we performed open surgery
because we predicted that manipulation of the area
around the pancreas would result in bleeding. Indeed,
the tissues around the pancreas bled easily; the amount
of bleeding was 1,862 ml. We preserved the abnormally
expanded IMV because of the following reasons. First,
the abnormally expanded IMV is thought to become
thin if the feeding P-AVMs are resected and blood flow
is reduced. Second, ligation of the abnormally expanded
IMV can lead to blood stasis in the IMV, so the IMV
does not become thin. We did not perform ligation orembolization of the IMV in the first operation. As a result,
surgical treatment was successful and we could perform
safely radical laparoscopic surgery for rectal cancer.
In our case, the abnormally expanded IMV remained
after the first operation. Although the IMV was
thought to become thin because of the reduction in
blood flow, there was no supporting evidence. Intraop-
erative Doppler or blood gas analysis of the abnormally
expanded IMV could have confirmed the efficacy of
the treatment.
We added preoperative chemotherapy for the follow-
ing reason. After the initial operation, although the IMV
was occluded by the thrombi on POD 17, we did not
know at that time how long it would take for the IMV
to become thin. While waiting for the IMV to become
thin, we considered that a rectal cancer treatment such
as chemotherapy would be helpful. Furthermore, the
operation would be easier if the tumor were smaller
because it was located in the lower rectum.
The second operation involved laparoscopic surgery
because this procedure provides a better view, especially
in the intrapelvic space. Lateral lymph node dissection
was not performed because the lymph nodes were not
enlarged in preoperative CT.
Conclusions
We have described a patient with rectal cancer and ab-
normally expanded IMV resulting from P-AVMs, which
is believed to be the first case worldwide. Our case
revealed the efficacy of surgery for P-AVMs.
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